Ribavirin 13C5
| Product Name | Ribavirin 13C5 |
|---|---|
| Alternate Names | Ribavirin Stable Isotopes, Stable Isotopes of Ribavirin |
| CAT No. | CS-O-06923 |
| CAS No. | 1646818-35-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 249.17 g/mol |
| Mol. For. | C₃¹³C₅H₁₂N₄O₅ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ribavirin |
| Purity | 95% |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C(C1=NN([13C@H]2[13C@@H]([13C@@H]([13C@@H]([13CH2]O)O2)O)O)C=N1)N |
| Canonical Smiles | C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N |
| InchIKey | IWUCXVSUMQZMFG-GOZXRHHJSA-N |
| Inchl | InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4+,5?,8-/m1/s1/i1+1,3+1,4+1,5+1,8+1 |
| IUPAC | 1-[(2R,4R,5R)-3,4-dihydroxy-5-(hydroxy(113C)methyl)(2,3,4,5-13C4)oxolan-2-yl]-1,2,4-triazole-3-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ribavirin 13C5 is a stable isotope labeled form of ribavirin, a synthetic nucleoside analogue which is used in the treatment of viral infections. Ribavirin 13C5 is used in the treatment of chronic hepatitis C virus (HCV) infection, in combination with other antiviral drugs.
Chemically, Ribavirin 13C5 is a derivative of guanosine, and it works by inhibiting the replication of HCV by interfering with the synthesis of viral RNA. The isotope labeling of Ribavirin 13C5 makes it useful for pharmacokinetic studies, as it allows for the tracking of the drug in the body, and the measurement of its absorption, distribution, metabolism, and excretion.
Ribavirin 13C5 is administered orally, and the dosage and duration of treatment depends on the severity of the HCV infection, as well as other factors such as the patient's age, weight, and medical history. The drug is generally well-tolerated, but some side effects may occur, including fatigue, nausea, headache, and anemia.
Overall, Ribavirin 13C5 is an important tool in the fight against HCV, and its isotope labeling makes it a valuable asset in pharmacological research.
Get an Instant Quote
Related Compounds
Ribavirin 15N, D2 | Ribavirin 13C2 |